Skip Nav Destination
Article navigation
Retraction|
October 2005
AQUAVAN® Injection, a Water-soluble Prodrug of Propofol, as a Bolus Injection: A Phase I Dose-escalation Comparison with DIPRIVAN® (Part 1): Pharmacokinetics: Retracted
Ekaterina Gibiansky, Ph.D.;
Ekaterina Gibiansky, Ph.D.
*Head, Pharmacometrics, and Principal Scientist.
Search for other works by this author on:
Michel M. R. F. Struys, M.D., Ph.D.;
Michel M. R. F. Struys, M.D., Ph.D.
†Professor in Anesthesia and Research Coordinator.
Search for other works by this author on:
Leonid Gibiansky, Ph.D.;
Leonid Gibiansky, Ph.D.
‡Former position: Senior Statistician, Emmes Corporation, Rockville, Maryland. Current position: Principal Scientist, Metrum Research Group, Avon, Connecticut.
Search for other works by this author on:
Ann L. G. Vanluchene, M.D.;
Ann L. G. Vanluchene, M.D.
§Staff Anesthesiologist.
Search for other works by this author on:
James Vornov, M.D., Ph.D.;
James Vornov, M.D., Ph.D.
‖Director, Clinical Research, Guilford Pharmaceuticals Inc., Baltimore, Maryland.
Search for other works by this author on:
Eric P. Mortier, M.D., D.Sc.;
Eric P. Mortier, M.D., D.Sc.
#Professor in Anesthesia and Chair, Department of Anesthesia, Ghent University Hospital.
Search for other works by this author on:
Eric Burak, Ph.D.;
Eric Burak, Ph.D.
**Former position: Director of DMPK, Guilford Pharmaceuticals Inc., Baltimore, Maryland. Current position: Pharmacokineticist, Rib-X Pharmaceuticals, New Haven, Connecticut.
Search for other works by this author on:
Luc Van Bortel, M.D., Ph.D.
Luc Van Bortel, M.D., Ph.D.
††Professor, Clinical Pharmacology and Pharmacotherapy, Heymans Institute of Pharmacology, Ghent University and Head of Drug Research Unit Ghent, Ghent University Hospital.
Search for other works by this author on:
Anesthesiology October 2005, Vol. 103, 718–729.
Citation
Ekaterina Gibiansky, Michel M. R. F. Struys, Leonid Gibiansky, Ann L. G. Vanluchene, James Vornov, Eric P. Mortier, Eric Burak, Luc Van Bortel; AQUAVAN® Injection, a Water-soluble Prodrug of Propofol, as a Bolus Injection: A Phase I Dose-escalation Comparison with DIPRIVAN® (Part 1): Pharmacokinetics: Retracted. Anesthesiology 2005; 103:718–729 doi: https://doi.org/10.1097/00000542-200510000-00010
Download citation file:
Citing articles via
Most Viewed
Related Articles
AQUAVAN® Injection, a Water-soluble Prodrug of Propofol, as a Bolus Injection: A Phase I Dose-escalation Comparison with DIPRIVAN® (Part 2): Pharmacodynamics and Safety: Retracted
Anesthesiology (October 2005)
Comparative Pharmacokinetics and Pharmacodynamics of the New Propofol Prodrug GPI 15715 and Propofol Emulsion: Retracted
Anesthesiology (September 2004)
AQUAVAN Injection, a Water-soluble Prodrug of Propofol, as a Bolus Injection: A Phase I Dose-escalation Comparison with DIPRIVAN (Part 1): Pharmacokinetics: Retraction
Anesthesiology (April 2010)
AQUAVAN Injection, a Water-soluble Prodrug of Propofol, as a Bolus Injection: A Phase I Dose-escalation Comparison with DIPRIVAN (Part 2): Pharmacodynamics and Safety: Retraction
Anesthesiology (April 2010)
CORRECTION
Anesthesiology (November 2008)
